Ipsen S.A. (IPNN)
BMV
Closed
Aug 25, 2026
Day's Range
3,384.2752 wk Range
2,617.44Overview - IPNN - Ipsen S.A.
Key Statistics
Valuation
Enterprise Value
5.50T
P/E (Trailing)
‪27.70‬
Price / Sales (TTM)
‪65.11‬
Price / Book
‪2.99‬
EV / EBITDA
‪191.21‬
Profitability
Profit Margin
‪11.94%‬
Operating Margin
‪28.48%‬
Return on Assets
‪10.27%‬
Return on Equity
‪11.44%‬
Ownership
Shares Outstanding
82.60M
Float
29.96M
Held by Insiders
‪57.64%‬
Held by Institutions
‪21.27%‬
Price stats
Beta
‪0.32‬
50-Day Avg
‪3,195.34‬
200-Day Avg
‪2,894.22‬
Dividends
Payout Ratio
‪25.89%‬
Frequency
Annual
Peers - IPNN - Ipsen S.A.
Related Symbols
Other instruments in the same class.
Profile Summary - IPNN - Ipsen S.A.
About
Ipsen S.A. is a French biopharmaceutical company headquartered in Paris, specializing in the development and commercialization of transformative medicines across three core therapeutic areas: oncology, rare diseases, and neuroscience. Founded in 1929 by Dr. Henri Beaufour as a family business, it has evolved over…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
